Galectin Therapeutics (GALT) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.43% |
| Dec 31, 2025 | 53.75% |
| Sep 30, 2025 | -16.31% |
| Jun 30, 2025 | 85.32% |
| Sep 30, 2024 | 5.71% |
| Jun 30, 2024 | 8.67% |
| Mar 31, 2024 | -8.20% |
| Dec 31, 2023 | 26.02% |
| Sep 30, 2023 | 13.34% |
| Jun 30, 2023 | 0.94% |
| Sep 30, 2022 | -34.52% |
| Jun 30, 2022 | -23.50% |
| Sep 30, 2021 | 15.83% |
| Jun 30, 2021 | 52.21% |
| Mar 31, 2021 | -23.51% |
| Dec 31, 2020 | -16.63% |
| Sep 30, 2020 | -20.14% |
| Jun 30, 2020 | -5.91% |
| Mar 31, 2020 | -8.74% |
| Dec 31, 2019 | -5.68% |
| Sep 30, 2019 | -3.28% |
| Jun 30, 2019 | 646.46% |
| Mar 31, 2019 | -15.52% |
| Dec 31, 2018 | -18.58% |
| Sep 30, 2018 | -3.44% |
| Jun 30, 2018 | 163.21% |
| Mar 31, 2018 | 30.63% |
| Dec 31, 2017 | -56.12% |
| Sep 30, 2017 | -23.76% |
| Jun 30, 2017 | -33.11% |
| Mar 31, 2017 | -11.18% |
| Dec 31, 2016 | -4.34% |
| Sep 30, 2016 | -10.80% |
| Jun 30, 2016 | -19.47% |
| Mar 31, 2016 | -13.50% |
| Dec 31, 2015 | 21.23% |
| Sep 30, 2015 | -19.13% |
| Jun 30, 2015 | -10.18% |
| Mar 31, 2015 | 0.76% |
| Dec 31, 2014 | -6.64% |
| Sep 30, 2014 | -9.36% |
| Jun 30, 2014 | -5.93% |
| Mar 31, 2014 | 248.88% |
| Dec 31, 2013 | 7.97% |
| Sep 30, 2013 | 90.53% |
| Jun 30, 2013 | -27.34% |
| Mar 31, 2013 | -25.05% |
| Dec 31, 2012 | -15.33% |
| Sep 30, 2012 | -15.77% |
| Jun 30, 2012 | -14.26% |
| Mar 31, 2012 | 139.39% |
| Dec 31, 2011 | -19.47% |
| Sep 30, 2011 | -0.50% |
| Jun 30, 2011 | 14.91% |
| Mar 31, 2011 | 17.94% |
| Dec 31, 2010 | 109.35% |
| Sep 30, 2010 | -1.71% |